341 related articles for article (PubMed ID: 28429293)
1. Topical Delivery of Fenoprofen Calcium via Elastic Nano-vesicular Spanlastics: Optimization Using Experimental Design and In Vivo Evaluation.
Farghaly DA; Aboelwafa AA; Hamza MY; Mohamed MI
AAPS PharmSciTech; 2017 Nov; 18(8):2898-2909. PubMed ID: 28429293
[TBL] [Abstract][Full Text] [Related]
2. Microemulsion for topical delivery of fenoprofen calcium: in vitro and in vivo evaluation.
Farghaly DA; Aboelwafa AA; Hamza MY; Mohamed MI
J Liposome Res; 2018 Jun; 28(2):126-136. PubMed ID: 28081643
[TBL] [Abstract][Full Text] [Related]
3. Topical Nano-Vesicular Spanlastics of Celecoxib: Enhanced Anti-Inflammatory Effect and Down-Regulation of TNF-α, NF-кB and COX-2 in Complete Freund's Adjuvant-Induced Arthritis Model in Rats.
Alaaeldin E; Abou-Taleb HA; Mohamad SA; Elrehany M; Gaber SS; Mansour HF
Int J Nanomedicine; 2021; 16():133-145. PubMed ID: 33447032
[TBL] [Abstract][Full Text] [Related]
4. Enhanced non invasive trans-tympanic delivery of ciprofloxacin through encapsulation into nano-spanlastic vesicles: Fabrication, in-vitro characterization, and comparative ex-vivo permeation studies.
Al-Mahallawi AM; Khowessah OM; Shoukri RA
Int J Pharm; 2017 Apr; 522(1-2):157-164. PubMed ID: 28279741
[TBL] [Abstract][Full Text] [Related]
5. Formulation of Nanospanlastics as a Promising Approach for Improving the Topical Delivery of a Natural Leukotriene Inhibitor (3-Acetyl-11-Keto-β-Boswellic Acid): Statistical Optimization, in vitro Characterization, and ex vivo Permeation Study.
Badria F; Mazyed E
Drug Des Devel Ther; 2020; 14():3697-3721. PubMed ID: 32982176
[TBL] [Abstract][Full Text] [Related]
6. Response Surface Optimization of Ultra-Elastic Nanovesicles Loaded with Deflazacort Tailored for Transdermal Delivery: Accentuated Bioavailability and Anti-Inflammatory Efficacy.
Ali AA; Hassan AH; Eissa EM; Aboud HM
Int J Nanomedicine; 2021; 16():591-607. PubMed ID: 33531803
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of surfactant-based elastic vesicular system for transdermal delivery of Cilostazole:
Nemr AA; El-Mahrouk GM; Badie HA
J Liposome Res; 2022 Jun; 32(2):159-171. PubMed ID: 33970754
[TBL] [Abstract][Full Text] [Related]
8. Novel Luliconazole Spanlastic Nanocarriers: Development and Characterisation.
Marques SM; Chavan DU; Bhide PJ; Joshi M; Kumar L; Shirodkar RK
Curr Drug Deliv; 2023; 20(6):792-806. PubMed ID: 35578877
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of Transdermal Delivery of Haloperidol via Spanlastic Dispersions: Entrapment Efficiency vs. Particle Size.
Fahmy AM; El-Setouhy DA; Habib BA; Tayel SA
AAPS PharmSciTech; 2019 Jan; 20(3):95. PubMed ID: 30694404
[TBL] [Abstract][Full Text] [Related]
10. Terbinafine Hydrochloride Trans-ungual Delivery via Nanovesicular Systems: In Vitro Characterization and Ex Vivo Evaluation.
Elsherif NI; Shamma RN; Abdelbary G
AAPS PharmSciTech; 2017 Feb; 18(2):551-562. PubMed ID: 27138036
[TBL] [Abstract][Full Text] [Related]
11. Transdermal delivery of fluvastatin sodium
El Menshawe SF; Nafady MM; Aboud HM; Kharshoum RM; Elkelawy AMMH; Hamad DS
Drug Deliv; 2019 Dec; 26(1):1140-1154. PubMed ID: 31736366
[TBL] [Abstract][Full Text] [Related]
12. "Spanlastic nanovesicles for enhanced ocular delivery of vanillic acid: design, in vitro characterization, and in vivo anti-inflammatory evaluation".
Ibrahim SS; Abd-Allah H
Int J Pharm; 2022 Sep; 625():122068. PubMed ID: 35926753
[TBL] [Abstract][Full Text] [Related]
13. Topical delivery of l-ascorbic acid spanlastics for stability enhancement and treatment of UVB induced damaged skin.
Elhabak M; Ibrahim S; Abouelatta SM
Drug Deliv; 2021 Dec; 28(1):445-453. PubMed ID: 33620008
[TBL] [Abstract][Full Text] [Related]
14. Topical delivery of extracted curcumin as curcumin loaded spanlastics anti-aging gel: Optimization using experimental design and ex-vivo evaluation.
El Hosary R; Teaima MH; El-Nabarawi M; Yousry Y; Eltahan M; Bakr A; Aboelela H; Abdelmonem R; Nassif RM
Saudi Pharm J; 2024 Jan; 32(1):101912. PubMed ID: 38178851
[TBL] [Abstract][Full Text] [Related]
15. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.
Nagaich U; Gulati N
Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979
[TBL] [Abstract][Full Text] [Related]
16. Formulation and characterization of lamotrigine nasal insert targeted brain for enhanced epilepsy treatment.
Abdelmonem R; El-Enin HAA; Abdelkader G; Abdel-Hakeem M
Drug Deliv; 2023 Dec; 30(1):2163321. PubMed ID: 36579655
[TBL] [Abstract][Full Text] [Related]
17. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
Wen MM; Farid RM; Kassem AA
J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
[TBL] [Abstract][Full Text] [Related]
18. Topical ketoprofen nanogel: artificial neural network optimization, clustered bootstrap validation, and in vivo activity evaluation based on longitudinal dose response modeling.
Elkomy MH; Elmenshawe SF; Eid HM; Ali AM
Drug Deliv; 2016 Nov; 23(9):3294-3306. PubMed ID: 27066917
[TBL] [Abstract][Full Text] [Related]
19. Niosome-based hydrogel of resveratrol for topical applications: An effective therapy for pain related disorder(s).
Negi P; Aggarwal M; Sharma G; Rathore C; Sharma G; Singh B; Katare OP
Biomed Pharmacother; 2017 Apr; 88():480-487. PubMed ID: 28126673
[TBL] [Abstract][Full Text] [Related]
20. Spanlastics nanovesicular ocular insert as a novel ocular delivery of travoprost: optimization using Box-Behnken design and
Shukr MH; Ismail S; El-Hossary GG; El-Shazly AH
J Liposome Res; 2022 Dec; 32(4):354-364. PubMed ID: 35037560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
